Cargando…
Adherence of patients to oral oncolytic and neurologic specialty medications provided by a specialty pharmacy
Background: Specialty medications (SP-D) are high cost prescription medications designed for the treatment of complex chronic conditions, i.e. cancer and neurological diseases. Such medications require special handling and shipping, administration, and patient education. To achieve the desired treat...
Autores principales: | Bhusal, Binita, Oleru, Kiona, Arikian, Veronica, Jaster, Ryan, Stranz, Marc, Lindhorst, Justin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764476/ http://dx.doi.org/10.1080/21556660.2019.1658288 |
Ejemplares similares
-
POSC374 Association of COVID-19 on Adherence to Oral Specialty Pharmacy Oncology Medications and Quality of Life of Multiple Myeloma Patients
por: Burruss, R, et al.
Publicado: (2022) -
Adherence to oral oncolytics filled through an internal health-system specialty pharmacy compared with external specialty pharmacies
por: Academia, Emmeline C, et al.
Publicado: (2021) -
The Emergence of Specialty Pharmacy
por: Vanscoy, Gordon J.
Publicado: (2020) -
The Reemergence of Specialty Pharmacy
por: Vanscoy, Gannon, et al.
Publicado: (2020) -
Management of specialty drugs, specialty pharmacies and biosimilars in the United States
por: Brook, Richard A., et al.
Publicado: (2019)